0001817875-21-000001.txt : 20210716
0001817875-21-000001.hdr.sgml : 20210716
20210715200854
ACCESSION NUMBER: 0001817875-21-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210716
DATE AS OF CHANGE: 20210715
EFFECTIVENESS DATE: 20210716
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gaiamer Biotechnologies, Inc.
CENTRAL INDEX KEY: 0001817875
IRS NUMBER: 845169488
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-371022
FILM NUMBER: 211093877
BUSINESS ADDRESS:
STREET 1: 5768 LINDENHURST AVE.
CITY: LOS ANGELES
STATE: CA
ZIP: 90036
BUSINESS PHONE: 3239650063
MAIL ADDRESS:
STREET 1: 5768 LINDENHURST AVE.
CITY: LOS ANGELES
STATE: CA
ZIP: 90036
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001817875
Gaiamer Biotechnologies, Inc.
420 Hindry Ave. Unit A
Inglewood
CA
CALIFORNIA
90301
3239650063
DELAWARE
None
None
Corporation
true
2020
Charles
Caliman
1100 Wilshire Blvd.
#2809
Los Angeles
CA
CALIFORNIA
90017
Executive Officer
Director
Jihene
Dhaouadi
2105 East Broadway
Unit 308
Long Beach
CA
CALIFORNIA
90803
Director
Araya
Mesfin
600 Northpark Town Center 1200 Abernathy
Suite 1850
Atlanta
GA
GEORGIA
30328
Director
Christopher
Sargent
11206 Beecher Road
Flushing
MI
MICHIGAN
48433
Executive Officer
Director
Jerry
Schindler
4326 Oglethorpe Loop N.W.
Acworth
GA
GEORGIA
30101
Director
Keith
Tinsley
13536 Lakewood Blvd.
Bellflower
CA
CALIFORNIA
90706
Executive Officer
Director
Thomas
Trimbach
5768 Lindenhurst Ave.
Los Angeles
CA
CALIFORNIA
90036
Executive Officer
Director
Manufacturing
No Revenues
- 06b
true
0001817875-20-000001
2020-06-24
true
true
true
false
25000
Blue Horse Equity LLC
None
None
None
260 Newport Center Drive
Suite 100
Newport Beach
CA
CALIFORNIA
92660
AZ
ARIZONA
CA
CALIFORNIA
FL
FLORIDA
GA
GEORGIA
IL
ILLINOIS
MI
MICHIGAN
NV
NEVADA
NY
NEW YORK
TX
TEXAS
true
5000000
100000
4900000
false
1
600000
true
0
Stock-based commissions, the value of which is difficult to ascertain currently, will be paid to certain executive officers of the company in connection with the offering.
480000
true
false
Gaiamer Biotechnologies, Inc.
Charles Caliman
Charles Caliman
Director & General Counsel
2021-07-15